Immix Biopharma, Inc.IMMXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P45
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | -11.22% |
| Q2 2025 | -215.09% |
| Q1 2025 | -14.15% |
| Q4 2024 | 63.43% |
| Q3 2024 | 23.21% |
| Q2 2024 | -37.34% |
| Q1 2024 | -42.93% |
| Q4 2023 | 13.26% |
| Q3 2023 | 12.19% |
| Q2 2023 | -68.04% |
| Q1 2023 | 46.41% |
| Q4 2022 | -166.94% |
| Q3 2022 | -167.33% |
| Q2 2022 | 63.40% |
| Q1 2022 | -34.17% |
| Q4 2021 | -2094.87% |
| Q3 2021 | 67.88% |
| Q2 2021 | 40.70% |
| Q1 2021 | -267.65% |
| Q4 2020 | 321.60% |
| Q3 2020 | 70.84% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |